These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 14454906)

  • 1. [On the excretion of 5-aminolevulinic acid and porphobilinogen in latent porphyria].
    KELENYI G; ARATO G; BUDA V; ORBAN S
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1961; 78():205-13. PubMed ID: 14454906
    [No Abstract]   [Full Text] [Related]  

  • 2. Porphyria induced in the rabbit by diethyl 1,4-dihydro-2,4,6-trimethylpyridine-3,5-dicarboxylate. I. Excretion of 5-aminolaevulic acid, porphobilinogen, coproporphyrin and protoporphyrin.
    HAEGER-ARONSEN B
    Acta Pharmacol Toxicol (Copenh); 1961; 18():165-9. PubMed ID: 13903511
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the problem of treatment of acute intermittent porphyria with ovulation inhibitors. (Studies of delta-aminolevulinic acid, porphobilinogen and total porphyrin excretion)].
    Hocevar V; Rausch-Stroomann JG
    Klin Wochenschr; 1968 Oct; 46(20):1114-6. PubMed ID: 5706556
    [No Abstract]   [Full Text] [Related]  

  • 4. Excretion of porphobilinogen and 5-aminolaevulinic acid in acute porphyria.
    ACKNER B; COOPER JE; GRAY CH; KELLY M; NICHOLSON DC
    Lancet; 1961 Jun; 1(7189):1256-60. PubMed ID: 13681256
    [No Abstract]   [Full Text] [Related]  

  • 5. PORPHOBILINOGEN AND DELTA-AMINOLEVULINIC ACID EXCRETION IN MULTIPLE SCLEROSIS.
    TAYLOR JD; PAZDER LH; MARKLE V
    Can Med Assoc J; 1965 Jun; 92(26):1342-4. PubMed ID: 14312444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Excretion of delta-aminolevulinic acid and porphobilinogen in experimental porphyria in rabbits].
    JANOUSEK V; OCENASEK M
    Cesk Fysiol; 1960 Jan; 9():82-3. PubMed ID: 14406722
    [No Abstract]   [Full Text] [Related]  

  • 7. Urinary delta-aminolaevulic acid and porphobilinogen in different types of porphyria.
    HAEGER B
    Lancet; 1958 Sep; 2(7047):606-8. PubMed ID: 13588944
    [No Abstract]   [Full Text] [Related]  

  • 8. Excretion of porphobilinogen and Delta-aminolaevulinic acid in acute porphyria.
    WITH TK
    Lancet; 1961 Aug; 2(7200):485-6. PubMed ID: 13786050
    [No Abstract]   [Full Text] [Related]  

  • 9. [Qualitative demonstration of porphobilinogen in the urine in the framework of diagnosis of porphyria].
    Fillippini L; Siegenthaler W
    Dtsch Med Wochenschr; 1967 Apr; 92(15):718-9. PubMed ID: 6023750
    [No Abstract]   [Full Text] [Related]  

  • 10. [Porphyria and porphyrinuria].
    Schoenfeld N; Mamet R; Mevasser R; Atsmon A
    Harefuah; 1993 Dec; 125(12):449-52, 496. PubMed ID: 8112676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative determination of porphobilinogen and delta-aminolevulinic acid in the urine.
    MALOOLY DA; HIGHTOWER NC
    J Lab Clin Med; 1962 Apr; 59():568-74. PubMed ID: 14469034
    [No Abstract]   [Full Text] [Related]  

  • 12. Porphobilinogen and delta-amino levulinic acid in acute porphyria.
    GRANICK S; VANDEN SCHRIECK HG
    Proc Soc Exp Biol Med; 1955 Feb; 88(2):270-3. PubMed ID: 14357411
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of glycine loading on Delta-Aminolevulinic acid (ALA) and porphobilinogen (PBG) excretion during starvation.
    Deleña S; Brown H
    Metabolism; 1969 Nov; 18(11):901-5. PubMed ID: 5350555
    [No Abstract]   [Full Text] [Related]  

  • 14. [Porphyrins and their precursors in the urine of patients with suspected porphyria; a 16-year experience].
    Zawirska B; Kwiatkowska W; Nowojska A
    Pol Tyg Lek; 1985 Jan; 40(4):97-100. PubMed ID: 3983004
    [No Abstract]   [Full Text] [Related]  

  • 15. [Urinary excretion of porphyrins and their precursors. Longterm observations in acute intermittent porphyrias (author's transl)].
    Brugsch J; Müller H
    MMW Munch Med Wochenschr; 1979 Mar; 121(13):457-8. PubMed ID: 107424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repression of the overproduction of porphyrin precursors in acute intermittent porphyria by intravenous infusions of hematin.
    Bonkowsky HL; Tschudy DP; Collins A; Doherty J; Bossenmaier I; Cardinal R; Watson CJ
    Proc Natl Acad Sci U S A; 1971 Nov; 68(11):2725-9. PubMed ID: 5288250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delta-amino-levulinic acid, porphobilinogen, and porphyrin excretion throughout pregnancy in a patient with acute intermittent porphyria with "passive porphyria" in the infant.
    JAMES GW; RUDOLPH SG; ABBOTT LD
    J Lab Clin Med; 1961 Sep; 58():437-44. PubMed ID: 13789298
    [No Abstract]   [Full Text] [Related]  

  • 18. [On determination of porphobilinogen in urine].
    Iarlykova EI; Lorie IuI; Krasiukova LI
    Lab Delo; 1966; 6():347-9. PubMed ID: 4175724
    [No Abstract]   [Full Text] [Related]  

  • 19. The porphyrinogenic effects of kryptopyrrole in the rat and the occurrence of urinary kryptopyrrole in human hereditary hepatic porphyria.
    Brodie MJ; Graham DJ; Thompson GG; Moore MR; Goldberg A
    Clin Sci Mol Med; 1976 May; 50(5):431-4. PubMed ID: 1277751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitation of 3-ethyl-5-hydroxy-4,5-dimethyl-delta 3-pyrrolin-2-one in the urine of patients with acute intermittent porphyria.
    Graham DJ; Brodie MJ; McColl KE; Moore MR; Goldberg A
    Eur J Clin Invest; 1979 Feb; 9(1):49-53. PubMed ID: 110600
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.